Amoy Diagnostics Co., Ltd. Class A

Amoy Diagnostics Co., Ltd. Class A

SSZSE:300685
17.99
CNY
+0.03
(+0.17%)
0.87EPS
23.82P/E
8.32BMarket Cap
Apr 13Next Earn

Total Valuation

CNY

As of September 30, 2026, Amoy Diagnostics Co., Ltd. Class A carries a market capitalization of 8.32B, placing it among publicly traded companies globally. Its enterprise value stands at 7.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap8.32B
Enterprise Value7.23B

Important Dates

Amoy Diagnostics Co., Ltd. Class A's next confirmed earnings release is scheduled for April 13, 2027.

Earnings Date4/13/2027

Share Statistics

As of September 30, 2026, Amoy Diagnostics Co., Ltd. Class A has 390.11M shares outstanding.

Shares Outstanding390.11M

Valuation Ratios

As of September 30, 2026, Amoy Diagnostics Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 23.82. The price-to-sales ratio is 6.85, and the price-to-book ratio stands at 4.24.

PE Ratio23.82
PS Ratio6.85
PB Ratio4.24
P/TBV Ratio4.33

Enterprise Valuation

As of September 30, 2026, Amoy Diagnostics Co., Ltd. Class A trades at an EV/EBITDA multiple of 18.09 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 6.02 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 18.09 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 7.23B versus a market cap of 8.32B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales6.02
EV / EBITDA18.09
EV / EBIT18.09

Financial Position

As of September 30, 2026, Amoy Diagnostics Co., Ltd. Class A maintains a current ratio of 16.13, meaning it holds 16.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 8.56, indicating elevated leverage, while an interest coverage ratio of 131.64 demonstrates strong ability to service its debt obligations.

Current Ratio16.13
Quick Ratio10.28
Debt / Equity8.56
Debt / EBITDA0.42
Interest Coverage131.64

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Amoy Diagnostics Co., Ltd. Class A posted a return on equity (ROE) of 17.97, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 16.98 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 15.55, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 17.02, useful for judging operating efficiency across full business cycles. The company generates approximately 1.02M in revenue per employee across its workforce of 1,175.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.22 indicates how many times Amoy Diagnostics Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)17.97
Return on Assets (ROA)15.55
Return on Invested Capital (ROIC)16.98
Return on Capital Employed (ROCE)17.02
Revenue Per Employee1.02M
Employee Count1,175.00
Inventory Turnover5.22

Taxes

CNY

Over the twelve months ended September 30, 2026, Amoy Diagnostics Co., Ltd. Class A recorded 48.04M in income tax expense. That works out to an effective tax rate of 12.19, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 393.97M, leaving 345.93M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax48.04M
Effective Tax Rate12.19

Stock Price Statistics

CNY

As of the close on November 17, 2026, Amoy Diagnostics Co., Ltd. Class A's stock has declined approximately 22.79% over the past 52 weeks. The 50-day moving average sits at 18.80, while the 200-day moving average is 19.62.

52-Week Price Change-22.79%
50-Day Moving Average18.80
200-Day Moving Average19.62

Income Statement

CNY

Over the twelve months ended September 30, 2026, Amoy Diagnostics Co., Ltd. Class A generated 1.20B in revenue and converted that into 345.93M in net income, yielding earnings per share of 0.87. EBITDA reached 399.98M, while operating income came in at 434.15M.

Revenue1.20B
Gross Profit981.79M
Operating Income434.15M
Pretax Income393.97M
Net Income345.93M
EBITDA399.98M
EBIT399.98M
Earnings Per Share (EPS)0.87

Balance Sheet

CNY

As of September 30, 2026, Amoy Diagnostics Co., Ltd. Class A holds 1.26B in cash and equivalents against 168.23M in total debt, resulting in a net debt position of -948.53M. Total book value stands at 1.96B, with working capital of 1.85B providing operational flexibility.

Cash & Cash Equivalents1.26B
Total Debt168.23M
Net Debt-948.53M
Equity (Book Value)1.96B
Book Value Per Share5.04
Working Capital1.85B

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-60.18M

Margins

Over the twelve months ended September 30, 2026, Amoy Diagnostics Co., Ltd. Class A posted a gross margin of 81.69, reflecting its pricing power and cost economics. The operating margin of 36.12 and net profit margin of 28.78 provide insight into operational efficiency.

Gross Margin81.69
Operating Margin36.12
Pretax Margin32.78
Profit Margin28.78
EBITDA Margin33.28

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Amoy Diagnostics Co., Ltd. Class A paid dividends of 0.47 per share. The dividend payout ratio of 52.07 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 3.36, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Amoy Diagnostics Co., Ltd. Class A shareholders.

Dividend Per Share0.47
Payout Ratio52.07
Shareholder Yield3.36

Stock Splits

Amoy Diagnostics Co., Ltd. Class A's most recent stock split took place on May 31, 2022 with a 5:9 split ratio.

Last Split Date5/31/2022
Split Ratio5:9

Scores

As of September 30, 2026, Amoy Diagnostics Co., Ltd. Class A has an Altman Z-Score of 20.30, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score20.30